For Parkinson's disease, Levodopa is the preferred treatment in the clinic.
However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia.
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson's disease are correctable to an extent.
Advertisement
They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).
Source: Eurekalert
3D Microscopy May Help Crack Secrets of Alzheimer's
Scientists have edged closer to cracking Parkinson's and Alzheimer's secrets with the help of cutting edge 3D microscopy.
Advertisement
 Drug Holding Hope for Parkinson's DevelopedThe debilitating symptoms of Parkinson's disease in mice were found to be reduced by a drug meant to treat high blood pressure, reports a study. | Advertisement
|
Higher Levels of Vitamin D can Lower Risk of Parkinson's Disease
A study in Finland has shown that greater levels of Vitamin D is connected to lower risk of Parkinson's disease,researchers said.
Advertisement
Latest Research News
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.